Armata Pharmaceuticals, Inc.
ARMP
$1.87
-$0.14-6.97%
AMEX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -351.19% | 147.44% | -160.99% | 135.91% | -26.07% |
| Total Depreciation and Amortization | -0.79% | 21.41% | -0.63% | -0.63% | 8.19% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 98.11% | -338.26% | 85.33% | -219.00% | 45.18% |
| Change in Net Operating Assets | -200.67% | 227.17% | -41.45% | 60.93% | -403.77% |
| Cash from Operations | 4.38% | 10.56% | 12.91% | 3.85% | -30.57% |
| Capital Expenditure | -228.57% | 122.65% | 75.11% | -446.40% | 89.58% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -228.57% | 122.65% | 75.11% | -446.40% | 89.54% |
| Total Debt Issued | -- | -- | -- | -100.00% | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -100.00% | 109.52% | -- |
| Repurchase of Common Stock | -- | 100.00% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | 100.00% | -169.32% | -99.75% | 81,334.88% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 129.39% | 15.26% | 19.13% | -147.54% | 328.65% |